The Usability, Acceptability, and Perceived Value of the Cornerstones4Care Powered by Glooko App

Status unconfirmed · Not applicable

Conditions studied: Diabetes Mellitus, Type 2

In brief

This is a two-armed mixed methods study of participants (n=30) diagnosed with type 2 diabetes who use a blood glucose meter as part of their treatment regimen. Participants will have either two or three visits at HITLAB during the 28-day study period.

Key facts

Study ID

NCT03222284

Run by

Healthcare Innovation Technology Lab

People needed

30

Starts

2017-07-17

Expected to finish

2017-11-30

Last updated by the study team

2017-07-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Be diagnosed with type 2 diabetes
• Live in the New York Metropolitan area
• Be at least 18 years of age
• Able to read, write, and speak in English
• Have an iPhone or Android phone
• Use a blood glucose meter
• Regularly take insulin by injection
• Be willing to follow study requirements for a 28-day period

You may not qualify if…

• Not be diagnosed with type 2 diabetes
• Not living in the New York Metropolitan area
• Be less than 18 years of age
• Be unable to read, write, and speak in English
• Not have an iPhone or Android phone
• Not use a blood glucose meter
• Not regularly take insulin by injection
• Be unwilling to follow study requirements for a 28-day period

Where it is running

• Healthcare Innovation and Technology Lab — New York, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.